TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

TELCON RF PHARMACEUTICAL. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	30,495	33,055	70,587	97,673	110,233	255,964
Market Cap Growth	-32.91%	-53.17%	-27.73%	-11.39%	-56.93%	-50.53%
Enterprise Value	32,956	27,030	107,353	107,951	136,288	323,257
Last Close Price	846.00	917.00	1582.46	2353.47	2736.28	7885.33
PE Ratio	-	-	-	7.02	-	-
PS Ratio	0.71	0.77	1.86	2.69	3.96	6.76
PB Ratio	0.28	0.30	0.85	0.93	1.31	2.40
P/TBV Ratio	0.33	0.36	1.10	1.18	1.83	3.35
P/FCF Ratio	22.64	24.55	-	-	-	-
P/OCF Ratio	18.30	19.84	57.91	-	-	-
EV/Sales Ratio	0.76	0.63	2.84	2.97	4.90	8.54
EV/EBITDA Ratio	14.20	4.88	24.20	20.72	623.83	-
EV/EBIT Ratio	-	37.62	-	111.83	-	-
EV/FCF Ratio	24.47	20.07	-	-	-	-
Debt / Equity Ratio	0.32	0.32	0.67	0.26	0.36	0.53
Debt / EBITDA Ratio	6.18	6.18	12.55	5.26	138.58	-
Debt / FCF Ratio	25.45	25.45	-	-	-	-
Net Debt / Equity Ratio	0.02	0.02	0.55	0.16	0.24	0.31
Net Debt / EBITDA Ratio	0.39	0.39	10.29	3.25	94.03	-90.18
Net Debt / FCF Ratio	1.59	1.59	-12.18	-3.41	-7.05	-12.53
Asset Turnover	0.28	0.28	0.26	0.28	0.19	0.21
Inventory Turnover	6.56	6.56	5.55	5.57	4.99	6.71
Quick Ratio	0.89	0.89	0.27	0.56	0.47	0.55
Current Ratio	1.25	1.25	0.37	0.95	0.67	0.62
Return on Equity (ROE)	-11.91%	-11.91%	-28.18%	14.75%	-44.16%	-23.10%
Return on Assets (ROA)	0.29%	0.29%	-0.03%	0.46%	-1.77%	-1.62%
Return on Invested Capital (ROIC)	0.70%	0.60%	-0.06%	0.85%	-3.33%	-3.10%
Return on Capital Employed (ROCE)	0.70%	0.70%	-0.10%	0.90%	-4.80%	-4.20%
Earnings Yield	-37.57%	-34.66%	-37.29%	14.24%	-38.18%	-9.02%
FCF Yield	4.42%	4.07%	-5.31%	-5.07%	-2.64%	-1.02%
Buyback Yield / Dilution	-35.13%	-35.13%	20.94%	-8.89%	-56.33%	-2.65%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.